Eligibility

**NOTIFICATION**

From June 2023: No new studies will be eligible for the Musketeers' Memorandum until further notice. All existing studies can run as usual, but new studies will not be accepted for the process.

Musketeers' Memorandum Eligibility 

Not all studies are suitable for the Musketeers' Memorandum process.

Musketeers' Memorandum eligibility requires that the study:

• is adopted onto the NIHR CRN portfolio, with the managing specialty listed as Genetics;

• sponsors are party to the Musketeers' Memorandum Agreement (see Homepage for details);

• satisfies the rare genetic disease criteria of less than 5 in 10,000 of the general population;

• is a non-CTIMP study,  only including the collection of DNA, blood, saliva, or previously collected tissue samples and/or patient identification, consent, clinical & family information, including questionnaires.

• would benefit from recruitment through the UK Regional Genetics Centres and major genetics referral centres;

• does not use any other NHS services that will be a cost to the NHS organisation.